Clinical Trial Update: Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of gemcitabine, capecitabine, and bevacizumab in patients with metastatic or unresectable pancreatic cancer; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-12-24